Fig. 1 · Structure
Documents & Downloads
Brezivaptan
Vasopressin Receptor Antagonist
Brezivaptan is a selective vasopressin receptor antagonist that inhibits the activity of vasopressin, a key hormone involved in regulating water retention and blood pressure. This compound demonstrates potential therapeutic applications in conditions such as heart failure and hypertension by modulating renal and vascular function. Brezivaptan is an essential tool for research exploring the physiological roles of vasopressin and the development of related pharmacological interventions.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Antagonist |
| CAS Number | 1370444-22-6 |
| Applications | Vasopressin Receptor Antagonist |
| Formula | C25H30ClN5O3 |
| Molecular Weight | 483.99 |
| Synonyms | Brezivaptanum; TH1773; TS-121 |
| SMILES | O=C(CN1C(N(C2=CC=C(CCN3CCOCC3)C=C2)N=C1C4=CC(Cl)=CC=C4)=O)NC(C)C |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.